国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

OPINION> Commentary
Best options for tackling earth's killer diseases
By Dean T. Jamison and Bjorn Lomborg (China Daily)
Updated: 2008-05-23 07:28

Large parts of the world have not enjoyed the remarkable global progress in health conditions that have taken place over the past century. Indeed, millions of deaths in impoverished nations are avoidable with prevention and treatment options that the rich world already uses.

This year, 10 million children will die in low- and middle-income countries. If child death rates were the same as those in developed countries, this figure would be lower than 1 million. Conversely, if child death rates were those of rich countries just 100 years ago, the figure would be 30 million.

The key difference between now and then is not income but technical knowledge about the causes of disease, and interventions to prevent disease, or at least the most pernicious symptoms.

Today's tools for improving health are so powerful and inexpensive that health conditions could be reasonably good even in poor countries if policymakers spent even relatively little in the right places.

Recent research for the Copenhagen Consensus identifies several highly cost-effective options that would tackle some of the planet's most urgent health problems.

The most promising investment is in tuberculosis treatment. Some 90 percent of the 1.6 million tuberculosis deaths in 2003 occurred in low- and middle-income countries. Because tuberculosis affects working-age people, it can be a trigger of household poverty.

The cornerstone of control is prompt treatment using first-line drugs, which doesn't require a sophisticated health system. Spending $1 billion on tuberculosis treatment in a year would save 1 million lives. Because good health accompanies higher levels of national economic welfare in the long run, the economic benefits are worth $30 billion.

The second most cost-effective investment is tackling cardiovascular disease. Heart disease might not seem like a pressing issue for poor nations, but it represents more than a quarter of their death toll. Measures to reduce risk factors other than smoking - high intake of saturated animal fat, obesity, binge drinking of alcohol, physical inactivity, and low fruit and vegetable consumption - have had little success.

Treating acute heart attacks with inexpensive drugs is, however, cost-effective. Spending $200 million could avert several hundred thousand deaths, yielding benefits that are 25 times higher than the costs.

The third option is prevention and treatment of malaria. A billion dollars would expand the provision of insecticide-treated bed-nets and facilitate provision of highly effective treatment. This would save more than a million child deaths and produce economic benefits worth $20 billion. The nascent Affordable Medicines Facility-malaria is a particularly attractive mechanism for committing resources to malaria control.

The fourth alternative for policymakers is to focus on child health initiatives. The best measures are familiar ones: expanding immunization coverage, promoting breastfeeding, increasing the use of simple and cheap treatments for diarrhea and childhood pneumonia, ensuring widespread distribution of key micronutrients, and spreading the use of anti-retroviral drugs and breastfeeding substitutes to prevent mother-to-child HIV transmission.

The changes that we are advocating are designed to target specific areas of need instead of strengthening health system capacity. But there is an important exception: strengthening surgical capacity, particularly in local hospitals, can inexpensively (and often decisively) address abdominal conditions. Long-neglected investments in surgical capacity would yield high returns.

Even if the costs of all these initiatives were two or three times higher than we estimate, these efforts would still provide amazing opportunities to reduce health inequality and do good in the world.

Dean Jamison is an economist and professor in the School of Medicine at the University of California. Bjorn Lomborg is head of the Copenhagen Consensus Center The Korea Herald/Asia News Network

(China Daily 05/23/2008 page9)

通海县| 大宁县| 绥宁县| 拉萨市| 拉孜县| 临湘市| 兰考县| 济阳县| 扎赉特旗| 霍州市| 城市| 昌宁县| 京山县| 张北县| 开江县| 句容市| 环江| 全州县| 固阳县| 申扎县| 安溪县| 嘉义市| 蕲春县| 高雄县| 莱西市| 华宁县| 洮南市| 金川县| 阳泉市| 武城县| 镇坪县| 长岭县| 巴东县| 绥江县| 大港区| 南安市| 射洪县| 吉木乃县| 金坛市| 湖南省| 榕江县|